Your browser doesn't support javascript.
loading
Potential synthetic lethality for breast cancer: A selective sirtuin 2 inhibitor combined with a multiple kinase inhibitor sorafenib.
Wang, Hua-Li; Ma, Xue; Guan, Xin-Yuan; Song, Chen; Li, Guo-Bo; Yu, Ya-Mei; Yang, Ling-Ling.
Afiliação
  • Wang HL; Department of Clinical Oncology, The University of Hong Kong-Shenzhen Hospital, Shenzhen 518053, PR China; State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, and Collaborative Innovation Center of Biotherapy, Chengdu 610041, PR China.
  • Ma X; State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, and Collaborative Innovation Center of Biotherapy, Chengdu 610041, PR China.
  • Guan XY; Department of Clinical Oncology, The University of Hong Kong-Shenzhen Hospital, Shenzhen 518053, PR China.
  • Song C; College of Food and Bioengineering, Xihua University, Sichuan 610039, PR China.
  • Li GB; Key Laboratory of Drug-Targeting and Drug Delivery System of the Education Ministry, Sichuan Engineering Laboratory for Plant-Sourced Drug and Sichuan Research Center for Drug Precision Industrial Technology, West China School of Pharmacy, Sichuan University, Sichuan 610041, PR China.
  • Yu YM; State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, and Collaborative Innovation Center of Biotherapy, Chengdu 610041, PR China. Electronic address: yamei_yu@scu.edu.cn.
  • Yang LL; College of Food and Bioengineering, Xihua University, Sichuan 610039, PR China. Electronic address: yangll0808@sina.com.
Pharmacol Res ; 177: 106050, 2022 03.
Article em En | MEDLINE | ID: mdl-34973468

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Carcinoma Pulmonar de Células não Pequenas / Neoplasias Pulmonares / Antineoplásicos Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Carcinoma Pulmonar de Células não Pequenas / Neoplasias Pulmonares / Antineoplásicos Idioma: En Ano de publicação: 2022 Tipo de documento: Article